骨髓瘤发病与诊治进展：2013年欧洲血液学会年会报道

Advances in molecular pathogenesis and clinical therapy of multiple myeloma： a 2013 EHA annual meeting press releases

多发性骨髓瘤（MM）是一种发病率随年龄增长而增高的异质性疾病。2013年第18届欧洲血液学会（EHA）年会围绕MM，从浆细胞克隆演变的分子发病机制到新药治疗及复发难治患者的诊治观念更新等多个方面均有较多新内容。

Multiple myeloma （MM） is a genetically complex disease that is becoming more common in today＂ s aging population. In the 18th European Hematology Association （EHA） annual meeting, there were a number of key topics focusing on the development of MM from intraclonal heterogeneity, novel therapeutic agents, and relapse and refractory MM therapy, etc.